Imagine a digital hospital that lets people recover from strokes or brain injuries at home using VR headsets. Instead of slow paper tests, it uses games and AI to track how a patient is doing in real-time. It's like having a specialized therapist in your living room, making care accessible even in the middle of nowhere.
Neurological diagnosis and treatment are currently resource-intensive and rely on inaccurate pen-and-paper tests. This creates a bottleneck where professional shortages make care expensive and unavailable in rural areas.
A VR and AI-driven platform for remote screening, objective diagnostics, and personalized therapy programs for neurological disorders.
If you are a telemedicine platform provider dealing with a lack of specialized neuro-professionals — this project developed a remote evaluation and therapy tool that allows patients to train from home. This reduces the need for physical clinic visits and lowers the cost of healthcare services.
If you are a private rehabilitation clinic dealing with inefficient pen-and-paper diagnostic tools — this project developed objective VR diagnostics that help reach a diagnosis faster and more reliably. This allows for more accurate medication evaluation and faster reactions to patient performance changes.
If you are a support center dealing with the difficulty of screening large groups for ADHD or Autism — this project developed quick and efficient screening tools. This prevents limited resources from being wasted on patients who do not have neurological diseases.
Based on available project data, it addresses the lack of professionals by moving therapy to the patient's home, which reduces the high costs associated with limited availability of services in rural areas.
Yes, the project covers a range of neurological challenges including stroke, ADHD, Autism, Alzheimer, and Aphasia.
Based on available project data, the technology is developed by Peili Vision OY, but specific licensing terms are not provided.
It uses a web platform that allows doctors to assess the effect of medication and treatment accuracy based on the patient's everyday performance.
The project period is from 2022-11-01 to 2025-03-31.
The project is led by a single SME, Peili Vision OY from Finland, which holds 100% of the industry ratio. This lean structure suggests a fast-to-market approach where the company maintains full control over the intellectual property and product development without the complexity of a multi-partner academic consortium.
Contact Peili Vision OY in Finland
Contact us to explore licensing opportunities for VR neuro-rehabilitation tools.
